Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2009
|
| _version_ | 1797074450913427456 |
|---|---|
| author | Simes, R Voysey, M O'Connell, R Glasziou, P Best, J Scott, R Sullivan, DR Ehnholm, C Keech, A Sydney, U |
| author_facet | Simes, R Voysey, M O'Connell, R Glasziou, P Best, J Scott, R Sullivan, DR Ehnholm, C Keech, A Sydney, U |
| author_sort | Simes, R |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T23:36:21Z |
| format | Conference item |
| id | oxford-uuid:6dcbfd84-08cb-45d0-99a1-126cfd05d36c |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:36:21Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:6dcbfd84-08cb-45d0-99a1-126cfd05d36c2022-03-26T19:20:08ZLarger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD StudyConference itemhttp://purl.org/coar/resource_type/c_5794uuid:6dcbfd84-08cb-45d0-99a1-126cfd05d36cSymplectic Elements at Oxford2009Simes, RVoysey, MO'Connell, RGlasziou, PBest, JScott, RSullivan, DREhnholm, CKeech, ASydney, U |
| spellingShingle | Simes, R Voysey, M O'Connell, R Glasziou, P Best, J Scott, R Sullivan, DR Ehnholm, C Keech, A Sydney, U Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study |
| title | Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study |
| title_full | Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study |
| title_fullStr | Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study |
| title_full_unstemmed | Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study |
| title_short | Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study |
| title_sort | larger effects of fenofibrate on cvd in marked diabetic dyslipidemia are not explained by higher use of statin therapy the field study |
| work_keys_str_mv | AT simesr largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT voyseym largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT oconnellr largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT glaszioup largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT bestj largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT scottr largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT sullivandr largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT ehnholmc largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT keecha largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy AT sydneyu largereffectsoffenofibrateoncvdinmarkeddiabeticdyslipidemiaarenotexplainedbyhigheruseofstatintherapythefieldstudy |